Penumbra
PEN
#1709
Rank
HK$91.61 B
Marketcap
HK$2,340
Share price
2.02%
Change (1 day)
24.85%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Earnings for Penumbra (PEN)

Earnings in 2025 (TTM): HK$1.45 Billion

According to Penumbra's latest financial reports the company's current earnings are HK$1.33 Billion. In 2024 the company made an earning of HK$0.17 Billion a decrease over its 2023 earnings that were of HK$0.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Penumbra from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$1.45 B741.01%
2024 HK$0.17 B-66.43%
2023 HK$0.51 B991.52%
2022 HK$47.32 M-181.08%
2021 -HK$58.37 Million-80.74%
2020 -HK$0.31 Billion-181.97%
2019 HK$0.36 B58.45%
2018 HK$0.23 B2473.65%
2017 HK$9.06 M-186.3%
2016 -HK$10.51 Million-132.3%
2015 HK$32.51 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Inari Medical
NARI
-HK$0.42 Billion-128.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merit Medical
MMSI
HK$1.40 B-3.23%๐Ÿ‡บ๐Ÿ‡ธ USA